Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitr

British Journal of Pharmacology

Volumn 157, Issue 6, 2009, Pages 962-973

  Gauthaman, K ^a   Manasi, N ^a   Bongso, A ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Cell proliferation; Isoprenoids; Pluripotency; Statins; Stem cells

Indexed keywords

COMPACTIN; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; GLUCOSE REGULATED PROTEIN 94; GROWTH DIFFERENTIATION FACTOR 3; GROWTH FACTOR; ISOPRENOID; MEVINOLIN; OCTAMER TRANSCRIPTION FACTOR 4; PRAVASTATIN; PROTEIN BAX; SIMVASTATIN; STAGE SPECIFIC EMBRYO ANTIGEN 4; SURVIVIN; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG INHIBITION; EMBRYONIC STEM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GENETIC VARIATION; GROWTH INHIBITORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 70350346624     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00241.x     Document Type: Article

References (44)

1. Clevers H (2005). Stem cells, asymmetric division and cancer. Nat Genet 37: 1027-1028. (Pubitemid 41486650)
2. Collins R, Armitage J, Parish S, Sleigh P, Peto R (2003). Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (9374): 2005-2016.
3. Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freed-man MH et al. (2001). Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apop-tosis: therapeutic implications. Clin Cancer Res 7: 158-167.
4. Edwards PA, Ericsson J (1999). Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Ann Rev Biochem 68: 157-185.
5. Ezeh UI, Turek PJ, Reijo RA, Clark AT (2005). Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104 (10): 2255-2265.
6. Gauthaman K, Richards M, Wong J, Bongso A (2007). Comparative evaluation of the effects of statins on human stem and cancer cells in vitro. Reprod BioMed Online 15 (5): 566-581.
7. Gniadecki R (2004). Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis. Biochem Biophys Res Commun 320: 165-169.
8. Goldstein JL, Brown MS (1990). Regulation of the mevalonate pathway. Nature 343: 425-430.
9. Green DR, Evan GI (2002). A matter of life and death. Cancer Cell 1: 19-30.
10. Hawk E, Viner JL (2005). Statins and cancer-beyond the 'one drug, one disease' model. N Engl J Med 352: 2238-2239.
11. Hindler K, Cleeland CS, Rivera E, Collard CD (2006). The role of statins in cancer therapy. Oncologist 11 (3): 306-315.
12. Hornstein E, Benvenisty N (2004). The 'brainy side' of human embryonic stem cells. J Neurosci Res 76: 169-173.
13. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infracted rat hearts. Nat Biotechnol 25 (9): 1015-1024.
14. Lee MH, Cho YS, Han YM (2007). Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranayl gera-nylation. Stem Cells 25 (7): 1654-1663.
15. Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H et al. (2003). A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 170: 1524-1530.
16. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R (2002). Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99: 4391-4396.
17. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC et al. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584.
18. Li L, Patty M, Nicholas LK, Bailey R, Hamilton AD, Sebti SM et al. (1999). Integrin-dependent leukocyte adhesion involves gera-nylgeranylated protein(s). J Biol Chem 274: 33334-33340.
19. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods 25: 402-408.
20. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K et al. (2005). Genomic alterations in cultured human embryonic stem cells. Nat Genet 37 (10): 1099-1103.
21. Maltese WA (1990). Post-translational modification of proteins by isoprenoids in mammalian cells. FASEB J 4: 3319-3328.
22. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG et al. (2002). Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419: 634-637.
23. Moyad MA, Merrick GS (2005). Statins and cholesterol lowering after a cancer diagnosis: why not? Urol Oncol 23: 49-55.
24. Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, Opthof T et al. (2002). Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 200: 233-242. (Pubitemid 34467315)
25. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993). Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.
26. Plaia TW, Josephson R, Liu Y, Zeng X, Ording C, Toumadje A et al. (2006). Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research. Stem Cells 24: 531-546.
27. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS et al. (2005). Statins and the risk of colorectal cancer. N Engl J Med 352: 2184-2192.
28. Rao S, Porter DC, Chen X, Herliczek T, Lowe M, Keyomarsi K (1999). Lovastatin-mediated G1 arrest is through inhibition of the protea-some, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci USA 96: 7797-7802.
29. Rattan R, Giri S, Singh AK, Singh I (2006). Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res 83 (2): 243-255.
30. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18: 399-404.
31. Richards M, Tan SP, Tan JH, Chan WK, Bongso A (2004). The tran-scriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22: 51-64. (Pubitemid 38018781)
32. Sathananthan AH, Pera M, Trounson AO (2002). The fine structure of human embryonic stem cells. Reprod BioMed Online 4: 56-61.
33. Shim JH, Kim SE, Woo DH, Kim SK, Oh CH, McKay R et al. (2007). Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 50: 1228-1238.
34. Sleijfer S, van der Gaast A, Planting AS, Stoter G, Verweij J (2005). The potential of statins as part of anti-cancer treatment. Eur J Cancer 41: 516-522.
35. Sottile V, Thomson A, McWhir J (2003). In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 5: 149-155.
36. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
37. Topol EJ (2004). Intensive statin therapy-a sea change in cardiovascular prevention. N Engl J Med 350: 1562-1564.
38. Ukomadu C, Dutta A (2003). p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J Biol Chem 278: 43586-43594.
39. van Vliet AK, van Thiel GC, Huisman RH, Moshage H, Yap SH, Cohen LH (1995). Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types. Biochim Biophys Acta 1254: 105-111.
40. Wachtershauser A, Akoglu B, Stein J (2001). HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22: 1061-1067.
41. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25 (6): 681-686.
42. Werner N, Nickenig G, Laufs U (2002). Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol 97: 105-116.
43. Wong RC, Pébay A, Nguyen LT, Koh KL, Pera MF (2004). Presence of functional gap junctions in human embryonic stem cells. Stem Cells 22: 883-889.
44. Yang D, Zhang Z, Oldenberg M, Ayala M, Zhang S (2008). Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in Parkinsonian rats. Stem Cells 26: 55-63.